Literature DB >> 27568929

KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1.

Sarah J Wong1, Micah D Gearhart2, Alexander B Taylor1, David R Nanyes1, Daniel J Ha1, Angela K Robinson1, Jason A Artigas3, Oliver J Lee3, Borries Demeler1, P John Hart4, Vivian J Bardwell2, Chongwoo A Kim5.   

Abstract

KDM2B recruits H2A-ubiquitinating activity of a non-canonical Polycomb Repression Complex 1 (PRC1.1) to CpG islands, facilitating gene repression. We investigated the molecular basis of recruitment using in vitro assembly assays to identify minimal components, subcomplexes, and domains required for recruitment. A minimal four-component PRC1.1 complex can be assembled by combining two separately isolated subcomplexes: the DNA-binding KDM2B/SKP1 heterodimer and the heterodimer of BCORL1 and PCGF1, a core component of PRC1.1. The crystal structure of the KDM2B/SKP1/BCORL1/PCGF1 complex illustrates the crucial role played by the PCGF1/BCORL1 heterodimer. The BCORL1 PUFD domain positions residues preceding the RAWUL domain of PCGF1 to create an extended interface for interaction with KDM2B, which is unique to the PCGF1-containing PRC1.1 complex. The structure also suggests how KDM2B might simultaneously function in PRC1.1 and an SCF ubiquitin ligase complex and the possible molecular consequences of BCOR PUFD internal tandem duplications found in pediatric kidney and brain tumors.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27568929      PMCID: PMC5088048          DOI: 10.1016/j.str.2016.07.011

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  27 in total

1.  Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.

Authors:  Takeshi Suzuki; Ken-ichi Minehata; Keiko Akagi; Nancy A Jenkins; Neal G Copeland
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

2.  NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.

Authors:  Filippos Kottakis; Parthena Foltopoulou; Ioannis Sanidas; Patricia Keller; Ania Wronski; Benjamin T Dake; Scott A Ezell; Zhu Shen; Stephen P Naber; Philip W Hinds; Elizabeth McNiel; Charlotte Kuperwasser; Philip N Tsichlis
Journal:  Cancer Res       Date:  2014-05-22       Impact factor: 12.701

3.  FBXL10 protects Polycomb-bound genes from hypermethylation.

Authors:  Mathieu Boulard; John R Edwards; Timothy H Bestor
Journal:  Nat Genet       Date:  2015-04-06       Impact factor: 38.330

Review 4.  Regulation of Genome Architecture and Function by Polycomb Proteins.

Authors:  Marianne Entrevan; Bernd Schuettengruber; Giacomo Cavalli
Journal:  Trends Cell Biol       Date:  2016-05-16       Impact factor: 20.808

Review 5.  Targeting Polycomb systems to regulate gene expression: modifications to a complex story.

Authors:  Neil P Blackledge; Nathan R Rose; Robert J Klose
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-30       Impact factor: 94.444

6.  Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.

Authors:  Ning Zheng; Brenda A Schulman; Langzhou Song; Julie J Miller; Philip D Jeffrey; Ping Wang; Claire Chu; Deanna M Koepp; Stephen J Elledge; Michele Pagano; Ronald C Conaway; Joan W Conaway; J Wade Harper; Nikola P Pavletich
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

7.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

Review 8.  Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put.

Authors:  Jeffrey A Simon; Robert E Kingston
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

9.  Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.

Authors:  Jin He; Li Shen; Ma Wan; Olena Taranova; Hao Wu; Yi Zhang
Journal:  Nat Cell Biol       Date:  2013-03-17       Impact factor: 28.824

10.  Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.

Authors:  Angshumoy Roy; Vijetha Kumar; Barry Zorman; Erica Fang; Katherine M Haines; HarshaVardhan Doddapaneni; Oliver A Hampton; Simon White; Abhishek A Bavle; Nimesh R Patel; Karen W Eldin; M John Hicks; Dinesh Rakheja; Patrick J Leavey; Stephen X Skapek; James F Amatruda; Jed G Nuchtern; Murali M Chintagumpala; David A Wheeler; Sharon E Plon; Pavel Sumazin; D Williams Parsons
Journal:  Nat Commun       Date:  2015-11-17       Impact factor: 14.919

View more
  22 in total

Review 1.  The critical role of histone lysine demethylase KDM2B in cancer.

Authors:  Meina Yan; Xinxin Yang; Hui Wang; Qixiang Shao
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Histone H2A Monoubiquitination in Neurodevelopmental Disorders.

Authors:  Anshika Srivastava; Brian McGrath; Stephanie L Bielas
Journal:  Trends Genet       Date:  2017-06-29       Impact factor: 11.639

3.  PARP1-dependent recruitment of the FBXL10-RNF68-RNF2 ubiquitin ligase to sites of DNA damage controls H2A.Z loading.

Authors:  Gergely Rona; Domenico Roberti; Yandong Yin; Julia K Pagan; Harrison Homer; Elizabeth Sassani; Andras Zeke; Luca Busino; Eli Rothenberg; Michele Pagano
Journal:  Elife       Date:  2018-07-09       Impact factor: 8.140

4.  KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.

Authors:  Yusuke Isshiki; Yaeko Nakajima-Takagi; Motohiko Oshima; Kazumasa Aoyama; Mohamed Rizk; Shuhei Kurosawa; Atsunori Saraya; Takashi Kondo; Emiko Sakaida; Chiaki Nakaseko; Koutaro Yokote; Haruhiko Koseki; Atsushi Iwama
Journal:  Blood Adv       Date:  2019-09-10

5.  BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.

Authors:  Yu-Chien Kao; Adepitan A Owosho; Yun-Shao Sung; Lei Zhang; Yumi Fujisawa; Jen-Chieh Lee; Leonard Wexler; Pedram Argani; David Swanson; Brendan C Dickson; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-05       Impact factor: 6.394

6.  A small-molecule Skp1 inhibitor elicits cell death by p53-dependent mechanism.

Authors:  Muzammal Hussain; Yongzhi Lu; Muqddas Tariq; Hao Jiang; Yahai Shu; Shuang Luo; Qiang Zhu; Jiancun Zhang; Jinsong Liu
Journal:  iScience       Date:  2022-06-14

7.  A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.

Authors:  Maryna Gorelik; Noah Manczyk; Alevtina Pavlenco; Igor Kurinov; Sachdev S Sidhu; Frank Sicheri
Journal:  Structure       Date:  2018-07-19       Impact factor: 5.006

8.  A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Authors:  Anastasios Kyriazoglou; Natalia Tourkantoni; Michalis Liontos; Flora Zagouri; Louisa Mahaira; Alexandra Papakosta; Dimitra Michali; Amalia Patereli; Kalliopi Stefanaki; Vasiliki Tzotzola; Evangelia Skoura; Margarita Baka; Sofia Polychronopoulou; Antonis Kattamis; Efthymios Dimitriadis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

Review 9.  New advances in the molecular classification of pediatric mesenchymal tumors.

Authors:  Albert J H Suurmeijer; Yu-Chien Kao; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2018-10-11       Impact factor: 5.006

10.  Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.

Authors:  Claudia Paret; Johanna Theruvath; Alexandra Russo; Bettina Kron; Khalifa El Malki; Nadine Lehmann; Arthur Wingerter; Marie A Neu; Aslihan Gerhold-Ay; Wolfgang Wagner; Clemens Sommer; Torsten Pietsch; Larissa Seidmann; Jörg Faber
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.